Visningssätt för begreppens/termernas förhållanden:
Det sätt begreppsrelationer visas:
Det sätt begreppsrelationer visas:
Tumörproteiner
Hierarki: | ∟ ∟ ∟ Tumörproteiner 98 sidobegrepp5 underordnad begrepp∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Amyloid | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Lektiner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Peptoner | ∟ ∟ Prioner | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Proteom | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Serpiner | ∟ Siden | ∟ ∟ ∟ ∟ ∟ ∟ ∟ TIMP | ∟ ∟ ∟ Tymosin | ∟ ∟ ∟ ∟ ∟ ∟ |
Bredare villkor: | |
Snävare villkor: | |
Anmärkning: | Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (TUMOR MARKERS, BIOLOGICAL) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
X |
Annotation: | IM & coord with specific protein (IM) + specific histol type (IM) + specific organ/neoplasms term (IM); Manual 24.4.4.4
X |
activeMeSHYear*: | |
dateCreated*: | 1999-01-01X |
dateEstablished*: | 1963-01-01X |
dateRevised*: | 2005-06-30X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | SYSTEMX |
recordOriginator*: | NLMX |
Relaterad term: | |
Typ: | |
Samordna villkor: | |
URI: | |
Termer och motsvarande begrepp: | Kasvainproteiinit (fi) XTuumoriproteiinit (fi, ersatt) Tuumoriproteiini (fi, ersatt) Syöpäproteiinit (fi, ersatt) Syöpäproteiini (fi, ersatt) Kasvainproteiini (fi, ersatt) Cancerproteiner (sv, ersatt) Neoplasm Proteins (en) |
Dela: |
Laddar resultat...